Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Novartis
Federal Trade Commission
Chinese Patent Office
Fish and Richardson
UBS
Deloitte
Cerilliant
Dow
Fuji

Generated: August 20, 2017

DrugPatentWatch Database Preview

ATOVAQUONE Drug Profile

« Back to Dashboard

What is the patent landscape for Atovaquone, and what generic Atovaquone alternatives are available?

Atovaquone is a drug marketed by Paddock Llc, Amneal Pharms, Glenmark Generics, and Mylan Pharms Inc. and is included in four NDAs.

The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.

Summary for Tradename: ATOVAQUONE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list73
Clinical Trials: see list32
Patent Applications: see list2,634
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATOVAQUONE at DailyMed

Pharmacology for Tradename: ATOVAQUONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
ATOVAQUONE
atovaquone
SUSPENSION;ORAL207833-001Apr 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-001Jan 12, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
ATOVAQUONE
atovaquone
SUSPENSION;ORAL202960-001Mar 18, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-002Apr 6, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL202362-002May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Daiichi Sankyo
Julphar
Chinese Patent Office
Merck
Cerilliant
AstraZeneca
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot